Search

everythinglearnresearchcommunity

for

Search:↓

The growth factor cocktail with FGF9 significantly increased hair density and diameter in patients with androgenetic alopecia.

Fibroblast growth factors could be a better, safer treatment for hair loss than current options.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Folliculin slows hair growth, and blocking it might help treat hair loss.

Hyaluronate fragments can help reverse skin thinning by working with the CD44 receptor.

Contact allergies might contribute to frontal fibrosing alopecia.

Nanofiber scaffolds help wounds heal by delivering drugs directly to the injury site.

Stem cell factor and certain proteins help melanocytes from hair follicles move and attach better, aiding vitiligo repigmentation.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

A-PRF+ improves bone healing and stability in oral surgery.

Poly(ADP-ribose) synthesis is linked to skin cell differentiation.

Microneedle delivery of a special collagen shows promise for treating hair loss.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Normal cells stain well with fluorescent globulin, but tumor cells do not.

Hair and wool strength is affected by the number and type of bonds in their protein structures, with hair having more protein aggregates than wool.

Combining certain treatments, including FOL005, may improve healing of difficult wounds.

A treatment called Cellcurin, combined with microneedling, significantly increased hair density and diameter in patients with hair loss.

Fibrosis contributes to hair loss in androgenetic alopecia, and targeting it may improve treatment.

Different types of human skin cells respond uniquely to various colors and doses of light, which could lead to specialized light treatments for skin conditions.

Trichoscopy is useful for diagnosing Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Intermediate filaments are crucial for cell differentiation and stem cell function.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Mouse epidermal growth factor injections in sheep affected wool growth and skin, but saline did not.

DFMO may help control hair growth and treat cancer.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Serum ferritin is a better indicator than hemoglobin for detecting low iron in women with chronic hair loss.